{"id":"policosanol","rwe":[{"pmid":"41756299","year":"2026","title":"Cytoprotective role of octacosanol in lipopolysaccharide-induced inflammation.","finding":"","journal":"Frontiers in immunology","studyType":"Clinical Study"},{"pmid":"41754781","year":"2026","title":"Combination of Policosanol (Raydel(®)) and Atorvastatin Improve High-Density Lipoproteins and Antioxidant Abilities to Protect Vital Organs and Fertility in Hyperlipidemic/Hyperglycemic Zebrafish.","finding":"","journal":"Pharmaceuticals (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"41674682","year":"2026","title":"Comprehensive metabolomics and phytochemical analyses identified important metabolites involved in the antioxidant activity of four Swiss chard cultivars (Beta vulgaris L. var. cicla) with different leaf colours.","finding":"","journal":"Food chemistry: X","studyType":"Clinical Study"},{"pmid":"41561167","year":"2025","title":"Policosanol alleviates chronic stress-induced growth impairment via gut microbiota-metabolite interactions: insights from 16S rRNA sequencing and LC-MS metabolomics.","finding":"","journal":"Frontiers in nutrition","studyType":"Clinical Study"},{"pmid":"41462653","year":"2025","title":"Cuban Sugarcane Wax Alcohol Supplementation Prevents Brain and Eye Damages of Zebrafish Exposed to High-Cholesterol and High-Galactose Diet for 30 Weeks: Protection of Myelin, Cornea, and Retina.","finding":"","journal":"Antioxidants (Basel, Switzerland)","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"C10AX08","category":"atc"},{"label":"Active","category":"status"},{"label":"Anticholesteremic Agents","category":"pharmacology"},{"label":"Antimetabolites","category":"pharmacology"},{"label":"Hematologic Agents","category":"pharmacology"},{"label":"Hypolipidemic Agents","category":"pharmacology"},{"label":"Lipid Regulating Agents","category":"pharmacology"},{"label":"Platelet Aggregation Inhibitors","category":"pharmacology"}],"phase":"phase_3","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["policosanol"],"offLabel":[],"synonyms":["policosanol"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like factories that produce cholesterol. Policosanol is like a brake that slows down this production process, which can help lower cholesterol levels in the blood. This can be beneficial for people at risk of heart disease.","oneSentence":"Policosanol is thought to work by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol synthesis.","technicalDetail":"Policosanol is believed to exert its effects by competitively inhibiting the activity of HMG-CoA reductase, a key enzyme in the mevalonate pathway responsible for cholesterol biosynthesis."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5074","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=POLICOSANOL","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=POLICOSANOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:26:26.589954","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:39:32.616512+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"dextrothyroxine","drugSlug":"dextrothyroxine","fdaApproval":"1967-04-14","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"probucol","drugSlug":"probucol","fdaApproval":"1977-02-01","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"ezetimibe","drugSlug":"ezetimibe","fdaApproval":"2002-10-25","patentExpiry":"Apr 30, 2026","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"mipomersen","drugSlug":"mipomersen","fdaApproval":"2013-01-29","patentExpiry":"Jan 29, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"lomitapide","drugSlug":"lomitapide","fdaApproval":"2012-12-21","patentExpiry":"Aug 19, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"evolocumab","drugSlug":"evolocumab","fdaApproval":"2015-08-28","relationship":"same-class"},{"drugName":"alirocumab","drugSlug":"alirocumab","fdaApproval":"2015-07-24","relationship":"same-class"},{"drugName":"bempedoic acid","drugSlug":"bempedoic-acid","fdaApproval":"2020-02-21","patentExpiry":"Mar 14, 2036","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"inclisiran","drugSlug":"inclisiran","fdaApproval":"2021-12-22","patentExpiry":"May 10, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"evinacumab","drugSlug":"evinacumab","fdaApproval":"2021-02-11","relationship":"same-class"}],"genericName":"policosanol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"dextrothyroxine","brandName":"dextrothyroxine","genericName":"dextrothyroxine","approvalYear":"1967","relationship":"same-class"},{"drugId":"probucol","brandName":"probucol","genericName":"probucol","approvalYear":"1977","relationship":"same-class"},{"drugId":"ezetimibe","brandName":"ezetimibe","genericName":"ezetimibe","approvalYear":"2002","relationship":"same-class"},{"drugId":"mipomersen","brandName":"mipomersen","genericName":"mipomersen","approvalYear":"2013","relationship":"same-class"},{"drugId":"lomitapide","brandName":"lomitapide","genericName":"lomitapide","approvalYear":"2012","relationship":"same-class"},{"drugId":"evolocumab","brandName":"evolocumab","genericName":"evolocumab","approvalYear":"2015","relationship":"same-class"},{"drugId":"alirocumab","brandName":"alirocumab","genericName":"alirocumab","approvalYear":"2015","relationship":"same-class"},{"drugId":"bempedoic-acid","brandName":"bempedoic acid","genericName":"bempedoic acid","approvalYear":"2020","relationship":"same-class"},{"drugId":"inclisiran","brandName":"inclisiran","genericName":"inclisiran","approvalYear":"2021","relationship":"same-class"},{"drugId":"evinacumab","brandName":"evinacumab","genericName":"evinacumab","approvalYear":"2021","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT05365425","phase":"PHASE4","title":"Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia","status":"RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2023-06-01","conditions":["Dyslipidemia","Atherosclerosis","Diabetes Mellitus, Type 2"],"enrollment":56,"completionDate":"2026-12-31"},{"nctId":"NCT00255216","phase":"NA","title":"Policosanol for the Treatment of Hypercholesterolemia","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2005-01","conditions":["Hyperlipidemia"],"enrollment":40,"completionDate":"2005-08"},{"nctId":"NCT03430284","phase":"PHASE4","title":"Multifactorial Intervention on Diabetes (MIDiab Study)","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2018-04-01","conditions":["Diabetes Mellitus, Type 2"],"enrollment":6300,"completionDate":"2022-12-31"},{"nctId":"NCT03470376","phase":"PHASE4","title":"NUtraceutical TReatment for hYpercholesterolemia in HIV-infected Patients","status":"COMPLETED","sponsor":"University Of Perugia","startDate":"2017-01-15","conditions":["Hypercholesterolemia","Inflammation","Atherosclerosis"],"enrollment":26,"completionDate":"2017-11-30"},{"nctId":"NCT02088307","phase":"NA","title":"Study of the Cardiovascular Vitamin, CardioLife","status":"COMPLETED","sponsor":"University of Utah","startDate":"2013-06","conditions":["Cardiovascular Disease"],"enrollment":21,"completionDate":"2016-01"},{"nctId":"NCT01293162","phase":"","title":"The Role of a Combination of Nutraceuticals in the Control of Cardiovascular Risk","status":"COMPLETED","sponsor":"Federico II University","startDate":"2010-09","conditions":["Metabolic Syndrome"],"enrollment":150,"completionDate":"2014-10"},{"nctId":"NCT01371058","phase":"PHASE4","title":"Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)","status":"COMPLETED","sponsor":"Shenyang Northern Hospital","startDate":"2011-03","conditions":["Coronary Artery Disease"],"enrollment":350,"completionDate":"2013-09"},{"nctId":"NCT00510809","phase":"NA","title":"Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy","status":"COMPLETED","sponsor":"James Backes, PharmD","startDate":"2007-07","conditions":["High Cholesterol"],"enrollment":54,"completionDate":"2010-05"},{"nctId":"NCT02543099","phase":"PHASE3","title":"Efficacy and Safety Study of Policosanol","status":"UNKNOWN","sponsor":"General Hospital of Chinese Armed Police Forces","startDate":"2015-06","conditions":["Endothelial Dysfunction"],"enrollment":100,"completionDate":"2016-06"},{"nctId":"NCT02422927","phase":"PHASE4","title":"Nutraceutical Combination in Patients With Low-grade Systemic Inflammation","status":"COMPLETED","sponsor":"University Of Perugia","startDate":"2014-07","conditions":["Atherosclerosis","Inflammation","Hypercholesterolemia"],"enrollment":100,"completionDate":"2015-02"},{"nctId":"NCT02001883","phase":"PHASE4","title":"Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2013-11","conditions":["Coronary Artery Disease"],"enrollment":100,"completionDate":"2015-12"},{"nctId":"NCT01965990","phase":"","title":"VLCD by Enteral Route for Weight Loss","status":"COMPLETED","sponsor":"San Giuseppe Moscati Hospital","startDate":"2010-04","conditions":["Severe Obesity"],"enrollment":364,"completionDate":"2013-02"},{"nctId":"NCT00312923","phase":"PHASE2","title":"Preliminary Study of Safety and Efficacy of Policosanol","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2005-09","conditions":["Dyslipidemia","HIV Infections"],"enrollment":54,"completionDate":"2009-09"},{"nctId":"NCT01807078","phase":"PHASE4","title":"Cholesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant Patients","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2014-01","conditions":["Coronary Artery Disease"],"enrollment":200,"completionDate":"2017-12"},{"nctId":"NCT01649986","phase":"PHASE4","title":"Nutraceuticals to Improve Lipid Profile in European Countries","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2014-01","conditions":["Hyperlipidemia"],"enrollment":100,"completionDate":"2017-12"},{"nctId":"NCT01490229","phase":"PHASE4","title":"Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2013-01","conditions":["Coronary Artery Disease"],"enrollment":100,"completionDate":"2016-12"},{"nctId":"NCT01562080","phase":"PHASE2,PHASE3","title":"Combined Effects of Bioactive Compounds in Lipid Profile","status":"COMPLETED","sponsor":"Rottapharm Spain","startDate":"2012-01","conditions":["Hyperlipidemia","Low-density-lipoprotein-type","Elevated Triglycerides"],"enrollment":118,"completionDate":"2012-10"},{"nctId":"NCT01087632","phase":"NA","title":"Armolipid Plus and Metabolic Syndrome","status":"COMPLETED","sponsor":"Rottapharm","startDate":"2009-09","conditions":["Metabolic Syndrome"],"enrollment":66,"completionDate":"2010-07"},{"nctId":"NCT00457756","phase":"NA","title":"The Effect of BiosLife on Serum Lipids","status":"COMPLETED","sponsor":"University of Utah","startDate":"2007-01","conditions":["Hypercholesterolemia"],"enrollment":100,"completionDate":"2007-07"},{"nctId":"NCT00654459","phase":"","title":"Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function","status":"COMPLETED","sponsor":"Federico II University","startDate":"2007-07","conditions":["Hyperlipidemia","Endothelial Dysfunction"],"enrollment":50,"completionDate":"2008-04"},{"nctId":"NCT00288483","phase":"PHASE3","title":"Cholesterol-Lowering Effects of Policosanol","status":"TERMINATED","sponsor":"Drug Commission of the German Medical Association","startDate":"2000-09","conditions":["Hypercholesterolemia","Combined Hyperlipidemia"],"enrollment":0,"completionDate":"2001-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"MMSL":"24086","NDDF":"008265","VANDF":"4021483","RXNORM":"69440","UMLSCUI":"C0215278","ChEMBL_ID":"CHEMBL3707352","PUBCHEM_CID":"1031","SNOMEDCT_US":"412484001","MESH_SUPPLEMENTAL_RECORD_UI":"C080710"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":320,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"C10AX08","allCodes":["C10AX08"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026","pmid":"41756299","title":"Cytoprotective role of octacosanol in lipopolysaccharide-induced inflammation.","journal":"Frontiers in immunology"},{"date":"2026 Jan 29","pmid":"41754781","title":"Combination of Policosanol (Raydel(®)) and Atorvastatin Improve High-Density Lipoproteins and Antioxidant Abilities to Protect Vital Organs and Fertility in Hyperlipidemic/Hyperglycemic Zebrafish.","journal":"Pharmaceuticals (Basel, Switzerland)"},{"date":"2026 Feb","pmid":"41674682","title":"Comprehensive metabolomics and phytochemical analyses identified important metabolites involved in the antioxidant activity of four Swiss chard cultivars (Beta vulgaris L. var. cicla) with different leaf colours.","journal":"Food chemistry: X"},{"date":"2025","pmid":"41561167","title":"Policosanol alleviates chronic stress-induced growth impairment via gut microbiota-metabolite interactions: insights from 16S rRNA sequencing and LC-MS metabolomics.","journal":"Frontiers in nutrition"},{"date":"2025 Dec 3","pmid":"41462653","title":"Cuban Sugarcane Wax Alcohol Supplementation Prevents Brain and Eye Damages of Zebrafish Exposed to High-Cholesterol and High-Galactose Diet for 30 Weeks: Protection of Myelin, Cornea, and Retina.","journal":"Antioxidants (Basel, Switzerland)"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"POLICOSANOL","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Policosanol is a nutraceutical that has been studied in clinical trials for various conditions, including coronary artery disease, hypercholesterolemia, diabetes mellitus, type 2, dyslipidemia, and atherosclerosis. It has been compared to ezetimibe in a clinical trial for statin-intolerant patients, but the results of this comparison are not specified in the provided information.","enrichmentLevel":5,"visitCount":0,"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:39:32.616512+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}